Inotiv, Inc. (NOTV)

Market Cap	106.14M
Revenue (ttm)	490.74M
Net Income (ttm)	-108.45M
Shares Out	26.02M
EPS (ttm)	-4.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,239,800
Open	3.800
Previous Close	3.840
Day's Range	3.755 - 4.339
52-Week Range	1.230 - 11.420
Beta	3.64
Analysts	Strong Buy
Price Target	5.92 (+45.1%)
Earnings Date	Feb 5, 2025

About NOTV

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 24, 1997
• Employees: 2,055
• Stock Exchange: NASDAQ
• Ticker Symbol: NOTV
• Website: https://www.inotivco.com

Financial Performance

In 2024, Inotiv's revenue was $490.74 million, a decrease of -14.27% compared to the previous year's $572.43 million. Losses were -$108.45 million, 3.14% more than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for NOTV stock is "Strong Buy." The 12-month stock price forecast is $5.92, which is an increase of 45.10% from the latest price.

Price Target

$5.92

(45.10% upside)

Analyst Consensus: Strong Buy